All Stories

Korro lays off 20% of staff to fund genetic med trials, Novo Nordisk partnership

Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its clinical-stage candidate for a genetic lung and liver disease.

May 8, 2025 - 23:17
 0
Korro lays off 20% of staff to fund genetic med trials, Novo Nordisk partnership
Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its clinical-stage candidate for a genetic lung and liver disease.
Read More

Tags:

Previous Article

NKGen CEO puts skin in the game, investing $2.6M to move biotech toward Alzheime...

Next Article

RallyBio cuts deeper, laying off 40% of workforce after halting work on lead drug

Related Posts

Sanofi hands back cancer NK cell engager to Innate amid autoimmune pivot

Sanofi hands back cancer NK cell engager to Innate amid...

Apr 23, 2025  0

New NIH grant rules override the Civil Rights Act of 1964, barring recipients from DEI activities

New NIH grant rules override the Civil Rights Act of 19...

Apr 21, 2025  0

GE HealthCare rolls out new AI-equipped SPECT/CT nuclear medicine scanner

GE HealthCare rolls out new AI-equipped SPECT/CT nuclea...

May 8, 2025  0